Companies seek second GLP-1 revolution—in pill form

Smaller, easier to make drug compounds could treat obesity and diabetes with fewer side effects.

Authors

Publication Details

Journal
Science
Published
2025-04-17
DOI
https://doi.org/10.1126/science.ady2624
Citations
1
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Companies seek second GLP-1 revolution—in pill form

Rachel Brazil
1 citations
Science
Pharmacology and Obesity Treatment
1.39
article

Companies seek second GLP-1 revolution—in pill form

Rachel Brazil
article en
1 citations

Abstract

Smaller, easier to make drug compounds could treat obesity and diabetes with fewer side effects.

ScienceVol. 388(6744)
Zero hunger
Openalex Percentile: Top 21%
Pharmacology and Obesity Treatment
1.39
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Companies seek second GLP-1 revolution—in pill form — Rachel Brazil · Science (2025) | TGRS Research Map | TGRS